DOCS.L

Dr. Martens plc
Dr. Martens PLC - Director/PDMR Shareholding
27th August 2024, 10:58
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8400B
Dr. Martens PLC
27 August 2024
 

Dr. Martens plc (the 'Company')

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

The Company announces that it has been notified that Lynne Weedall, Senior Independent Director and PDMR, purchased 25,000 ordinary shares of 1 pence each in the Company ('Ordinary Shares') on 27 August 2024 at a price of £0.7441448 per Ordinary Share.

The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Lynne Weedall

2

Reason for the notification

a)

Position/status

PDMR (Senior Independent Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01


ISIN: GB00BL6NGV24

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)


£0.7441448

25,000

d)

Aggregated information

 

-

Aggregated volume

-

Price

 

 

 

 

Single transaction

e)

Date of the transaction

27 August 2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

For further information please contact:

 

Bethany Barnes

Director of Investor Relations

bethany.barnes@drmartens.com

+4478 2518 7465

 

Paul Rolling

Assistant Company Secretary

paul.rolling@drmartens.com

+4475 8424 3562

                            

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBORRSNUWUAR]]>
TwitterFacebookLinkedIn